TREATMENT FOR SYNUCLEINOPATHIES

A method of treating or preventing synucleinopathies in a human subject comprising administering a therapeutically effective amount of a compound of Formula 1 or its pharmaceutically acceptable salt. L'invention concerne un procédé de traitement ou de prévention de synucléinopathies chez un suj...

Full description

Saved in:
Bibliographic Details
Main Authors DAMLE, Nitin Krishnaji, GOLDFINE, Andrew Michael, MANDHANE, Sanjaykumar Nandlal
Format Patent
LanguageEnglish
French
Published 17.12.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method of treating or preventing synucleinopathies in a human subject comprising administering a therapeutically effective amount of a compound of Formula 1 or its pharmaceutically acceptable salt. L'invention concerne un procédé de traitement ou de prévention de synucléinopathies chez un sujet humain, comprenant l'administration d'une quantité thérapeutiquement efficace d'un composé de formule 1 (formule 1) ou de ses sels pharmaceutiquement acceptables.
Bibliography:Application Number: WO2020IB55425